Transnational Drug Trafficking Act of 2013

Transnational Drug Trafficking Act of 2013 - Amends the Controlled Substances Import and Export Act to prohibit the manufacture or distribution of a controlled substance in schedule I or II, flunitrazepam, or a listed chemical by individuals having reasonable cause to believe that such substance or chemical will be unlawfully imported into the United States or into waters within 12 miles of the U.S. coast.

Prohibits the manufacture or distribution of a listed chemical: (1) intending or knowing that it will be used to manufacture a controlled substance; and (2) intending, knowing, or having reasonable cause to believe that the substance will be unlawfully imported into the United States.

Amends the federal criminal code to revise the prohibition against, and penalties for, intentionally trafficking in a counterfeit drug to apply to intentionally trafficking in a drug and knowingly using a counterfeit mark on or in connection with such drug.

[Congressional Bills 113th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2114 Introduced in House (IH)]

113th CONGRESS
  1st Session
                                H. R. 2114

 To provide the Department of Justice with additional tools to target 
  extraterritorial drug trafficking activity, and for other purposes.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                              May 22, 2013

  Mr. Marino (for himself and Mr. Pierluisi) introduced the following 
  bill; which was referred to the Committee on the Judiciary, and in 
 addition to the Committee on Energy and Commerce, for a period to be 
subsequently determined by the Speaker, in each case for consideration 
  of such provisions as fall within the jurisdiction of the committee 
                               concerned

_______________________________________________________________________

                                 A BILL


 
 To provide the Department of Justice with additional tools to target 
  extraterritorial drug trafficking activity, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Transnational Drug Trafficking Act 
of 2013''.

SEC. 2. POSSESSION, MANUFACTURE OR DISTRIBUTION FOR PURPOSES OF 
              UNLAWFUL IMPORTATIONS.

    Section 1009 of the Controlled Substances Import and Export Act (21 
U.S.C. 959) is amended--
            (1) by redesignating subsections (b) and (c) as subsections 
        (c) and (d), respectively; and
            (2) in subsection (a), by striking ``It shall'' and all 
        that follows and inserting the following: ``It shall be 
        unlawful for any person to manufacture or distribute a 
        controlled substance in schedule I or II or flunitrazepam or a 
        listed chemical intending, knowing, or having reasonable cause 
        to believe that such substance or chemical will be unlawfully 
        imported into the United States or into waters within a 
        distance of 12 miles of the coast of the United States.
    ``(b) It shall be unlawful for any person to manufacture or 
distribute a listed chemical--
            ``(1) intending or knowing that the listed chemical will be 
        used to manufacture a controlled substance; and
            ``(2) intending, knowing, or having reasonable cause to 
        believe that the controlled substance will be unlawfully 
        imported into the United States.''.

SEC. 3. TRAFFICKING IN COUNTERFEIT GOODS OR SERVICES.

    Chapter 113 of title 18, United States Code, is amended--
            (1) in section 2318(b)(2), by striking ``section 2320(e)'' 
        and insertion ``section 2320(f)''; and
            (2) in section 2320--
                    (A) in subsection (a), by striking paragraph (4) 
                and inserting the following:
            ``(4) traffics in a drug and knowingly uses a counterfeit 
        mark on or in connection with such drug,'';
                    (B) in subsection (b)(3), in the matter preceding 
                subparagraph (A), by striking ``counterfeit drug'' and 
                inserting ``drug that uses a counterfeit mark on or in 
                connection with the drug''; and
                    (C) in subsection (f), by striking paragraph (6) 
                and inserting the following:
            ``(6) the term `drug' means a drug, as defined in section 
        201 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 
        321).''.
                                 <all>